Arcturus Therapeutics
ARCT5.7900.70% ( +0.040 )
Arcturus Therapeutics (ARCT)
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its techn...
- Open
- 5.850
- High
- 5.900
- Low
- 5.615
- Prev. Close
- 5.750
- Volume
- 344.74K
- Turnover
- 1.98M
- Avg Price
- 5.740
- Bid/Ask Ratio
- --
- Amplitude
- 4.96%
- 52wk High
- 24.170
- Volume Ratio
- 0.81
- Turnover Ratio
- 1.32%
Arcturus Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$20.60255.79%
Forecast & RatingBuy
13analysts
- Strong buy69.23%
- Buy7.69%
- Hold23.08%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 1 day ago, 03:01 PM
Arcturus Therapeutics updates financial calendar with upcoming Q2 results release and conference call
- Global Report · 1 day ago, 04:12 AM
Cut the Earnings Season Noise: From AI Washing to Real Cash in 10 Outlier Stocks
- Global Report · Jul 21 at 04:13 AM
The Value Chain Dictates the Outcome: From Defense Platforms to Biotech Aggregators
- Market Beat · Jul 21 at 02:13 AM
Amova Asset Management Americas Inc. Grows Stock Holdings in Arcturus Therapeutics Holdings Inc. $ARCT
- Simplywall · Jul 15 at 12:12 PM
How New Forensics and mRNA Partnerships at Thermo Fisher Scientific (TMO) Have Changed Its Investment Story
- Global Report · Jul 14 at 06:47 AM
Biotech Reorganizes While Industrials and Consumer Discretionary Navigate Pricing Pressures
